+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

  • ID: 5134761
  • Report
  • July 2020
  • Region: Asia Pacific
  • 104 pages
  • GMD Research
1 of 4

Order now to receive an updated version of this report covering the impact of COVID-19.

Enquire Now

FEATURED COMPANIES

  • 3M Health Care Limited
  • Adherium Limited
  • AsthmaMD
  • AstraZeneca plc
  • Cohero Health
  • GlaxoSmithKline plc
  • MORE
Asia Pacific digital respiratory solutions market will grow by 41.6% annually with a total addressable market cap of $219.0 million over 2020-2030 owing to the rising demand for respiratory aids and air purification amid COVID-19 pandemic.

Highlighted with 31 tables and 42 figures, this 104-page report “Asia Pacific Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Therapeutic Devices
  • Inhalers
  • Nebulizers
Diagnostic Devices
  • Spirometers
  • Asthma Monitors
  • Other Diagnostic Devices
Sensors and Apps

Based on Indication, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • COVID-19 Caused Diseases
  • Other Diseases
Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Geographically, the following national/local markets are fully investigated:
  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Asia Pacific digital respiratory solutions market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • 3M Health Care Limited
  • Adherium Limited
  • Amiko Digital Health Limited
  • AsthmaMD
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Capsule Technologies, Inc.
  • Cohero Health
  • GlaxoSmithKline plc
  • Kaia Health Software GmbH
  • Medical International Research (MIR)
  • Novartis AG
  • NuvoAir
  • Reciprocal Labs (Propeller Health)
  • Sensiron AG
  • Tactio Health
  • Teva Pharmaceuticals Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3M Health Care Limited
  • Adherium Limited
  • AsthmaMD
  • AstraZeneca plc
  • Cohero Health
  • GlaxoSmithKline plc
  • MORE
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis

3 Segmentation of Asia Pacific Market by Product Type
3.1 Market Overview by Product Type
3.2 Therapeutic Devices
3.2.1 Inhalers
3.2.2 Nebulizers
3.3 Diagnostic Devices
3.3.1 Spirometers
3.3.2 Asthma Monitors
3.3.3 Other Diagnostic Devices
3.4 Sensors and Apps

4 Segmentation of Asia Pacific Market by Indication
4.1 Market Overview by Indication
4.2 Asthma
4.3 Chronic Obstructive Pulmonary Disease (COPD)
4.4 COVID-19 Caused Diseases
4.5 Other Diseases

5 Segmentation of Asia Pacific Market by Distribution Channel
5.1 Market Overview by Distribution Channel
5.2 Hospital Pharmacies
5.3 Retail Pharmacies
5.4 Online Pharmacies

6 Asia-Pacific Market 2019-2030 by Country
6.1 Overview of Asia-Pacific Market
6.2 Japan
6.3 China
6.4 Australia
6.5 India
6.6 South Korea
6.7 Rest of APAC Region

7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
  • 3M Health Care Limited
  • Adherium Limited
  • Amiko Digital Health Limited
  • AsthmaMD
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Capsule Technologies, Inc.
  • Cohero Health
  • GlaxoSmithKline plc
  • Kaia Health Software GmbH
  • Medical International Research (MIR)
  • Novartis AG
  • NuvoAir
  • Reciprocal Labs (Propeller Health)
  • Sensiron AG
  • Tactio Health
  • Teva Pharmaceuticals Industries Ltd.
8 Investing in Asia Pacific Market: Risk Assessment and Management
8.1 Risk Evaluation of Asia Pacific Market
8.2 Critical Success Factors (CSFs)

List of Tables
Table 1. Snapshot of Asia Pacific Digital Respiratory Solutions Market, 2019-2030
Table 2. Main Product Trends and Market Opportunities in Asia Pacific Digital Respiratory Solutions Market
Table 3. Asia Pacific Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn
Table 4. Asia Pacific Digital Respiratory Solutions Market: Therapeutic Devices by Type, 2019-2030, $ mn
Table 5. Asia Pacific Digital Respiratory Solutions Market: Diagnostic Devices by Type, 2019-2030, $ mn
Table 6. Asia Pacific Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn
Table 7. Asia Pacific Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn
Table 8. APAC Digital Respiratory Solutions Market by Country, 2019-2030, $ mn
Table 9. Japan Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn
Table 10. Japan Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn
Table 11. Japan Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn
Table 12. China Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn
Table 13. China Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn
Table 14. China Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn
Table 15. Australia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn
Table 16. Australia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn
Table 17. Australia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn
Table 18. India Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn
Table 19. India Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn
Table 20. India Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn
Table 21. South Korea Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn
Table 22. South Korea Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn
Table 23. South Korea Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn
Table 24. Digital Respiratory Solutions Market in Rest of APAC by Country, 2019-2030, $ mn
Table 25. 3M Health Care Limited: Company Snapshot
Table 26. 3M Health Care Limited: Business Segmentation
Table 27. 3M Health Care Limited: Product Portfolio
Table 28. 3M Health Care Limited: Revenue, 2016-2018, $ mn
Table 29. 3M Health Care Limited: Recent Developments
Table 30. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030
Table 31. Critical Success Factors and Key Takeaways

List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Asia Pacific Digital Respiratory Solutions Market, 2019-2030, $ mn
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Digital Respiratory Solutions Market
Figure 7. GDP per capita in the World, 1960-2018, $ thousand
Figure 8. Forecast of Middle-class Population by Region, 2015-2030, million
Figure 9. Worldwide Connected Devices by Device Type, 2014-2022, billion units
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Digital Respiratory Solutions Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Five Forces Analysis of Asia Pacific Digital Respiratory Solutions Market
Figure 13. Breakdown of Asia Pacific Digital Respiratory Solutions Market by Product Type, 2019-2030, % of Sales Revenue
Figure 14. Asia Pacific Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%)
Figure 15. Asia Pacific Digital Respiratory Solutions Market: Therapeutic Devices, 2019-2030, $ mn
Figure 16. Asia Pacific Digital Respiratory Solutions Market: Inhalers, 2019-2030, $ mn
Figure 17. Asia Pacific Digital Respiratory Solutions Market: Nebulizers, 2019-2030, $ mn
Figure 18. Asia Pacific Digital Respiratory Solutions Market: Diagnostic Devices, 2019-2030, $ mn
Figure 19. Asia Pacific Digital Respiratory Solutions Market: Spirometers, 2019-2030, $ mn
Figure 20. Asia Pacific Digital Respiratory Solutions Market: Asthma Monitors, 2019-2030, $ mn
Figure 21. Asia Pacific Digital Respiratory Solutions Market: Other Diagnostic Devices, 2019-2030, $ mn
Figure 22. Asia Pacific Digital Respiratory Solutions Market: Sensors and Apps, 2019-2030, $ mn
Figure 23. Breakdown of Asia Pacific Digital Respiratory Solutions Market by Indication, 2019-2030, % of Sales Revenue
Figure 24. Asia Pacific Addressable Market Cap in 2020-2030 by Indication, Value ($ mn) and Share (%)
Figure 25. Asia Pacific Digital Respiratory Solutions Market: Asthma, 2019-2030, $ mn
Figure 26. Asia Pacific Digital Respiratory Solutions Market: Chronic Obstructive Pulmonary Disease (COPD), 2019-2030, $ mn
Figure 27. Asia Pacific Digital Respiratory Solutions Market: COVID-19 Caused Diseases, 2019-2030, $ mn
Figure 28. Asia Pacific Digital Respiratory Solutions Market: Other Diseases, 2019-2030, $ mn
Figure 29. Breakdown of Asia Pacific Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, % of Revenue
Figure 30. Asia Pacific Addressable Market Cap in 2020-2030 by Distribution Channel, Value ($ mn) and Share (%)
Figure 31. Asia Pacific Digital Respiratory Solutions Market: Hospital Pharmacies, 2019-2030, $ mn
Figure 32. Asia Pacific Digital Respiratory Solutions Market: Retail Pharmacies, 2019-2030, $ mn
Figure 33. Asia Pacific Digital Respiratory Solutions Market: Online Pharmacies, 2019-2030, $ mn
Figure 34. Breakdown of APAC Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue
Figure 35. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 36. Digital Respiratory Solutions Market in Japan, 2019-2030, $ mn
Figure 37. Digital Respiratory Solutions Market in China, 2019-2030, $ mn
Figure 38. Digital Respiratory Solutions Market in Australia, 2019-2030, $ mn
Figure 39. Digital Respiratory Solutions Market in India, 2019-2030, $ mn
Figure 40. Digital Respiratory Solutions Market in South Korea, 2019-2030, $ mn
Figure 41. Digital Respiratory Solutions Market in Rest of APAC, 2019-2030, $ mn
Figure 42. Growth Stage of Asia Pacific Digital Respiratory Solutions Industry over the Forecast Period
Note: Product cover images may vary from those shown
3 of 4
  • 3M Health Care Limited
  • Adherium Limited
  • Amiko Digital Health Limited
  • AsthmaMD
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Capsule Technologies, Inc.
  • Cohero Health
  • GlaxoSmithKline plc
  • Kaia Health Software GmbH
  • Medical International Research (MIR)
  • Novartis AG
  • NuvoAir
  • Reciprocal Labs (Propeller Health)
  • Sensiron AG
  • Tactio Health
  • Teva Pharmaceuticals Industries Ltd.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll